Cargando…
Impact of antibody framework residue V(H)-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
Anti-MUC1 single-chain Fv (scFv) fragments generated from the humanised antibody huHMFG1 had adequate antigen-binding properties but very poor stability irrespective of the applied linker or domain orientation. Mutagenesis of heavy-chain framework residue V(H)-71, previously described as a key resid...
Autores principales: | Krauss, J, Arndt, M A E, Zhu, Z, Newton, D L, Vu, B K, Choudhry, V, Darbha, R, Ji, X, Courtenay-Luck, N S, Deonarain, M P, Richards, J, Rybak, S M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409732/ https://www.ncbi.nlm.nih.gov/pubmed/15150594 http://dx.doi.org/10.1038/sj.bjc.6601759 |
Ejemplares similares
-
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1
por: Pericleous, L M, et al.
Publicado: (2005) -
Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.
por: Denton, G., et al.
Publicado: (1997) -
Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes
por: Marty, C, et al.
Publicado: (2002) -
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug
por: de Graaf, M, et al.
Publicado: (2002) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)